Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions

Exclusion Criteria

• •More than 3 visible oral mucosal lesions.
• •Post-intubation sore throat.
• •Corticosteroid use ongoing or within 3 days before inclusion.
• •NSAID use ongoing or within 3 days before inclusion.
• •Local treatment on the lesion ongoing or within 3 days before inclusion.
• •Non-opioid analgesics, including paracetamol, ongoing or within 3 days before inclusion, unless continued for at least 24 hours at the same daily dose as during the 24 hours before inclusion.
• •Weak or strong opioid analgesics ongoing or within 3 days before inclusion.
• •Signs suggesting a condition requiring additional investigations according to the investigator, except rapid streptococcal throat testing.
• •Signs suggesting a condition requiring corticosteroid prescription according to the investigator.
• •Systemic disease, such as rheumatoid arthritis, lupus, or Behçet disease.
• •Any contraindication listed in OROSEDAL instructions for use.
• •Known allergy to any OROSEDAL component, including glycerol, tamarind extract, mallow extract, benzyl alcohol, orange blossom flavoring, or xylitol.
• •Non-compliance with precautions for use listed in the instructions for use.